MediXall Group, Inc.: 10-Q filed 2018-06-29

Name: MediXall Group, Inc.: 10-Q filed 2018-06-29
Creator: MediXall Group, Inc.

What MediXall Group, Inc. reported in its quarterly report filed 2018-06-29 (fiscal Q1 2018): 17 published measures, 32 facts as tagged in accession 0001553350-18-000746.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-06-29
Fiscal period: fiscal Q1 2018
Accession: 0001553350-18-000746 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MediXall Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-03-31	403,746	USD
At 2017-12-31	367,746	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-03-31	-76,787	USD
At 2017-12-31	-224,535	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2018-03-31	186,925	USD
At 2017-12-31	191,440	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-1,011,863	USD	90
2017-01-01 to 2017-03-31	-388,822	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-603,611	USD	90
2017-01-01 to 2017-03-31	-510,407	USD	90

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-41,515	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-03-31	-8,347,697	USD
At 2017-12-31	-7,335,834	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-03-31	17,364	USD
At 2017-12-31	12,432	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	519,000	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-03-31	186,925	USD
At 2017-12-31	191,440	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-03-31	480,533	USD
At 2017-12-31	592,281	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	1,011,863	USD	90
2017-01-01 to 2017-03-31	388,822	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit
At 2018-03-31	62,231,545	shares
At 2017-12-31	59,222,382	shares
At 2016-11-22	2,595,379	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2018-03-31	8,208,413	USD
At 2017-12-31	7,051,812	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-1,011,863	USD	90
2017-01-01 to 2017-03-31	-388,822	USD	90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	1,000	USD	90

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	640,611	USD	90
2017-01-01 to 2017-03-31	705,375	USD	90

Inspect the source

Entity: MediXall Group, Inc. / CIK 0001601280
Captured: 2026-09-21T17:20:21.643Z
SEC response SHA-256: b6322b58d999c8a74b96274fe9d2bf7196a7223cedbe45a09c2d28d5c34a5827

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001601280.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))